Drug use in prisons: strategies for harm reduction (ANRS-PRIDE Program)

被引:1
|
作者
Michel, Laurent [1 ]
机构
[1] Ctr Pierre Nicole, Ctr Rech Epidemiol & Sante Populat, 27 Rue Pierre Nicole, F-75005 Paris, France
来源
CIENCIA & SAUDE COLETIVA | 2016年 / 21卷 / 07期
关键词
Prison; Drug use; Harm reduction; Recommendations; France; FRENCH PRISONS; PUBLIC-HEALTH; ACCESS; HIV; PREVALENCE; DISORDERS;
D O I
10.1590/1413-81232015217.28442015
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The existence of risky practices related to drug use inside prisons is a reality everywhere and is a major issue for the community as a whole. The level of implementation of harm reduction (HR) measures recommended by the World Health Organization (WHO) and the United Nations Office on Drugs and Crime (UNODC) is very often poor and reveals inadequate concern about public health issues in the prison environment, without any respect for the principle of equivalence for prevention and health assistance with the general community. In 2009, the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) developed a comprehensive research program focusing on the prevention of infectious risks in prison settings. Different steps were defined and scheduled, and included i) an inventory of harm reduction (HR) measures, ii) a qualitative survey on the reality of risky practices, iii) an assessment of the social acceptability of HR measures, and iv) an intervention trial exploring the feasibility of upgrading existing HR strategies. A progressive implementation of this program has shown it is feasible, but in France, it requires tenacity, simple long-term objectives, support from a scientific authority, pedagogical interventions for all involved, as well as constant discussion with the authorities. The implementation of this program in other countries is equally simple to manage.
引用
收藏
页码:2081 / 2088
页数:8
相关论文
共 50 条
  • [1] Harm-Reduction Strategies for Injection Drug Use
    Azores-Gococo, Nicole M.
    Fridberg, Daniel J.
    PSYCHIATRIC ANNALS, 2017, 47 (01) : 45 - 48
  • [2] ASSESSING INTRAVENOUS DRUG USERS' USE OF HARM REDUCTION STRATEGIES TO PREVENT BIOMEDICAL HARM
    Phillips, Kristina T.
    Rosenberg, Harold
    ANNALS OF BEHAVIORAL MEDICINE, 2007, 33 : S168 - S168
  • [3] Drug use patterns, harm reduction strategies and use of drug checking services in boom festival patrons
    Valente, Helena
    Martins, Daniel
    Pinto, Marta
    Fernandes, Jose Luis
    Barratt, Monica J.
    DRUGS HABITS AND SOCIAL POLICY, 2022, 23 (03): : 232 - 243
  • [4] Drug use and harm reduction in Afghanistan
    Todd C.S.
    Safi N.
    Strathdee S.A.
    Harm Reduction Journal, 2 (1)
  • [5] Harm Reduction Strategies for Opioid Use Disorder
    Laila Knio
    Noah Capurso
    Current Addiction Reports, 12 (1)
  • [6] Injection drug use and hepatitis C in Canada: The effectiveness of harm reduction strategies.
    Leonard, L
    Forrester, L
    Navarro, C
    Pelude, L
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S263 - S263
  • [7] Correction: Drug use and harm reduction in Afghanistan
    Catherine S Todd
    Naqibullah Safi
    Steffanie A Strathdee
    Harm Reduction Journal, 2 (1)
  • [8] Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concern
    Laurent Michel
    Caroline Lions
    Sara Van Malderen
    Julie Schiltz
    Wouter Vanderplasschen
    Karina Holm
    Torsten Kolind
    Felice Nava
    Nadja Weltzien
    Andrea Moser
    Marie Jauffret-Roustide
    Olivier Maguet
    Patrizia M Carrieri
    Cinzia Brentari
    Heino Stöver
    BMC Public Health, 15
  • [9] Setting goals for drug policy: harm reduction or use reduction?
    Caulkins, JP
    Reuter, P
    ADDICTION, 1997, 92 (09) : 1143 - 1150
  • [10] Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concern
    Michel, Laurent
    Lions, Caroline
    Van Malderen, Sara
    Schiltz, Julie
    Vanderplasschen, Wouter
    Holm, Karina
    Kolind, Torsten
    Nava, Felice
    Weltzien, Nadja
    Moser, Andrea
    Jauffret-Roustide, Marie
    Maguet, Olivier
    Carrieri, Patrizia M.
    Brentari, Cinzia
    Stoever, Heino
    BMC PUBLIC HEALTH, 2015, 15